Home » Posts tagged 'panetta partners limited'

Tag Archives: panetta partners limited

Tiziana Life Sciences #TILS – Exec Chairman Gabriele Cerrone purchases more shares

New York/London, 14 January 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on the 13 January 2020 it was informed that on that date, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought 28,500 Ordinary Shares at a price of 43 pence per Ordinary Share, as set out below.

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

1. Details of PDMR / person closely associated
a) Name Gabriele Cerrone/Panetta Partners Limited
2. Reason for the notification: On market acquisition
a) Position / status Executive Chairman
b) Initial notification /amendment Initial notification
3. Details of the issuer
a) Name Tiziana Life Sciences plc
b) LEI 213800CED47HI8PIOB36
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares
b) Identification code of the Financial Instrument GB00BKWNZY55
c) Nature of the transaction On market acquisition of ordinary shares
d) Price(s) and volume(s)
Price: 43 pence; Volume: 28,500
e) Aggregated information

– Aggregated volume

 

– Price

 

N/A

 

N/A

f) Date of the transaction 13 January 2020
g) Place of the transaction AIM

 

As a result of this transaction Mr Cerrone’s interests in the underlying ordinary shares of the Company increases from 64,318,425 (47.066%) to 64,346,925 (47.087%). Mr Cerrone’s interests in the ordinary shares of the Company are based on a holding of 63,680,404 ordinary shares held by Planwise Limited and voting rights in respect of 666,521 ordinary shares held by Panetta Partners Limited (as shares and via ADSs). Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

 

For more information go to http://www.tizianalifesciences.com

 

Contacts:

Tiziana Life Sciences plc

Gabriele Cerrone, Chairman and founder

+44 (0)20 7495 2379
Cairn Financial Advisers LLP (Nominated adviser)

Liam Murray / Jo Turner

+44 (0)20 7213 0883
Shore Capital (Broker)

Antonio Bossi / Fiona Conroy

+44 (0)20 7408 4050

Tiziana Life Sciences #TILS – Director Dealing, Exec Chairman Gabriele Cerrone purchases 12,500 ADSs

New York/London, 2 January 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on 31 December 2019, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought 12,500 ADSs each representing 5 ordinary shares of nominal value 3p each in the capital of the Company at a price of US$2.79 per ADS, as set out below.

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

1. Details of PDMR / person closely associated
a) Name Gabriele Cerrone/Panetta Partners Limited
2. Reason for the notification: On market acquisition
a) Position / status Executive Chairman
b) Initial notification /amendment Initial notification
3. Details of the issuer
a) Name Tiziana Life Sciences plc
b) LEI 213800CED47HI8PIOB36
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument ADS representing 5 Ordinary Shares of nominal value 3p each
b) Identification code of the Financial Instrument 88875G101
c) Nature of the transaction On market acquisition of ordinary shares
d) Price(s) and volume(s)
Price: US$2.79; Volume: 12,500
e) Aggregated information

– Aggregated volume

 

– Price

 

12,500

 

US$34,875

f) Date of the transaction 31 December 2019
g) Place of the transaction NASDAQ

As a result of this transaction Mr Cerrone’s interests in the underlying ordinary shares of the Company increases from 64,255,925 (47.020%) to 64,318,425 (47.066%). Mr Cerrone’s interests in the ordinary shares of the Company are based on a holding of 63,680,404 ordinary shares held by Planwise Limited and voting rights in respect of 638,021 ordinary shares held by Panetta Partners Limited (as shares and via ADSs). Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

For more information go to http://www.tizianalifesciences.com

Contacts:

Tiziana Life Sciences plc

Gabriele Cerrone, Chairman and founder

+44 (0)20 7495 2379
Cairn Financial Advisers LLP (Nominated adviser)

Liam Murray / Jo Turner

+44 (0)20 7213 0883
Shore Capital (Broker)

Antonio Bossi / Fiona Conroy

+44 (0)20 7408 4050
I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.